Japan Adds iPS Parkinson’s Therapy to Public Insurance at ¥55.3M Per Patient
Japan's iPS Parkinson's therapy enters public insurance at ¥55.3M per patient, forcing global insurers to rethink experimental exclusion clauses.
Player Type
Japan's iPS Parkinson's therapy enters public insurance at ¥55.3M per patient, forcing global insurers to rethink experimental exclusion clauses.
Egypt's FRA issued Decision No. 70 in May 2026, introducing three takaful operating models and mandatory Sharia boards — a governance overhaul for a…
EIOPA AI governance opinion mandates two-step impact assessments for EU insurers by August 2026, with €35M penalties for non-compliance with the EU AI Act.
Hong Kong's Insurance Authority closes RBC consultation extending infrastructure capital relief to general insurers and imposing a 100% crypto charge. Implementation target: December 31,…
FEMA Review Council backs private market expansion in NFIP reform push, urging a 2-3 year transition as the program's $22.5B debt mounts toward the…
Lloyd’s governance probe into former CEO John Neal puts London Market transparency standards to the test as Chair resists disclosure while Freshfields investigators press…
EIOPA finalises revised Solvency II supervisory guidelines effective January 2027: 26% fewer quarterly templates, a 21% risk margin reduction, and mandatory DORA compliance embedded…
FCA claims management review launched May 6, targeting misleading ads, unfair exit fees and unauthorized sign-ups—making Consumer Duty compliance in claims handling an active…
India insurance FDI cap lifted to 100% via automatic route—removing the 74% foreign ownership ceiling and opening the world's fastest-growing major insurance market to…
BNM fines Zurich Malaysia RM1.56M after two subsidiaries used an outdated sanctions database, failing to freeze a confirmed-match customer — a compliance failure with…